Evaluation of a method for the simultaneous detection of multiple tumor markers using a multiplex suspension bead array

被引:10
作者
Wang, Yajie [1 ,2 ,3 ]
Fang, Fang [1 ]
Shi, Congning [1 ]
Zhang, Xulong [4 ]
Liu, Li [2 ]
Li, Jiutong [5 ]
Zhou, Xuelei [5 ]
Yao, Jianer [5 ]
Kang, Xixiong [1 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Clin Lab Diag, Beijing 100050, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, Lab Clin Med Res, Beijing 100050, Peoples R China
[3] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China
[4] Capital Med Univ, Sch Basic Med Sci, Dept Immunol, Beijing 100069, Peoples R China
[5] Shanghai Tellgen Life Sci Co Ltd, Shanghai 201203, Peoples R China
关键词
Multiplex suspension bead array; Tumor marker; MICROSPHERE IMMUNOASSAY; QUANTITATION; CYTOKINES;
D O I
10.1016/j.clinbiochem.2012.07.087
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: To achieve higher tumor detection efficiency, we evaluated a multiplex assay for TM analysis based on the Luminex-100 multiplex suspension bead array. Design: The assay simultaneously determined the concentrations of nine TMs in 1114 human serum specimens (546 patients with tumors, 158 patients with non-tumor inflammatory diseases, and 410 normal controls). The nine TMs were AFP, CEA, CA125, CYFRA 21-1, CA242, f-PSA, t-PSA, NSE and free beta-hCG. The multiplex suspension bead assays were compared with conventional methods used in clinical laboratories. Results: The Luminex assay has the same levels of sensitivity, specificity and accuracy in the prediction of positive tumor specimens as conventional methods. Conclusion: Multiplex suspension bead arrays have promising applications in clinical laboratories. (C) 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1394 / 1398
页数:5
相关论文
共 13 条
[1]  
[Anonymous], 2008, DEFINING ESTABLISHIN
[2]  
Bellisario R, 2000, CLIN CHEM, V46, P1422
[3]   Simultaneous measurement of antibodies to three HIV-1 antigens in newborn dried blood-spot specimens using a multiplexed microsphere-based immunoassay [J].
Bellisario, R ;
Colinas, RJ ;
Pass, KA .
EARLY HUMAN DEVELOPMENT, 2001, 64 (01) :21-25
[4]   Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay [J].
Carson, RT ;
Vignali, DAA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 227 (1-2) :41-52
[5]   Issues and barriers to development of clinically useful tumor markers: A development pathway proposal [J].
Hammond, MEH ;
Taube, SE .
SEMINARS IN ONCOLOGY, 2002, 29 (03) :213-221
[6]   Cytokines as mediators for or effectors against rotavirus disease in children [J].
Jiang, B ;
Snipes-Magaldi, L ;
Dennehy, P ;
Keyserling, H ;
Holman, RC ;
Bresee, J ;
Gentsch, J ;
Glass, RI .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (06) :995-1001
[7]   Rational Testing Appropriate requesting of serum tumour markers [J].
Kilpatrick, Eric S. ;
Lind, Michael J. .
BRITISH MEDICAL JOURNAL, 2009, 339 :859
[8]   Development of internal controls for the Luminex instrument as part of a multiplex seven-analyte viral respiratory antibody profile [J].
Martins, TB .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (01) :41-45
[9]  
Ministry of Health of China, 2006, NAT GUID CLIN LAB PR
[10]   The promise of biomarkers in cancer screening and detection [J].
Negm, RS ;
Verma, M ;
Srivastava, S .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (06) :288-293